Financial Tearsheet
Company Overview
ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broaden access to better healthcare.
ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) system to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI -- at a fraction of the cost, and at the point-of-care.
ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease, which affects over 1 billion people globally.
Recent Financial News
IR Contacts
| Gregory FCA |
|
Joe Hassett
|
Stock Performance
| Today's Open | 0.9300 |
| Volume | 4.25 million |
| Day Range | 0.8500 - 1.1300 |
| 52 Week Range | 0.5990 - 2.2500 |
| Bid/Ask | 0.8950 / 0.9051 |
| Bid/Ask Size | 26,500 X 600 |
| Previous Close | 0.9299 |
| Market Cap | 13.04 million |
| Shares Outstanding | 14.5 million |
| Dividend/Yield | 0.0000 / 0.0000% |
| EPS (TTM) | -2.255100 |
| P/E Ratio (TTM) | N/A |
